Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

Vatorpodden

Vatorpodden 2018-05-09: Immunovia AB

In this episode of Vatorpodden we interview Mats Grahn, CEO of Immunovia, listed on Nasdaq Stockholm main market. Mats presents how and why the company was founded, the IMMRAY platform technology for diagnosing complex diseases in a very early stage, the launch of the first pancreatic cancer test, commercialization and financial targets.

Vatorpodden 2016-12-22: Immunovia AB

Podcast in Swedish. Interview with CEO Mats Grahn.

Vatorpodden 2016-09-30: Knight Cancer Institute visits Immunovia in Lund

Podcast in English. In this episode, we interview Immunovia’s CEO Mats Grahn and Dr. Joseph Carroll who is the Senior Director of Business Development & Commercialization at Knight Cancer Institute, OHSU in Portland, Oregon. The interview is followed by a special discussion between Mats and Joseph on the topic of cancer and diagnostics.

Vatorpodden 2016-07-11: Immunovia presents in English

Podcast in English. In this episode, we interview Immunovia’s Executive Chairman Carl Borrebaeck and the company’s CEO Mats Grahn.

Vatorpodden 2016-05-30: Immunovia AB

Podcast in Swedish. Guests are Mats Grahn, CEO, and Carl Borrebaeck, chairman of the board.

Vatorpodden 2016-02-26: Immunovia AB

Podcast in Swedish. Interview with Mats Grahn, CEO of Immunovia.